✦ LIBER ✦

Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome

✍ Scribed by Scott, Hamish S.; Blanch, Lianne; Guo, Xiao-Hui; Freeman, Craig; Orsborn, Annette; Baker, Elizabeth; Sutherland, Grant R.; Morris, C. Phillip; Hopwood, John J.

Book ID: 109918900
Publisher: Nature Publishing Group
Year: 1995
Tongue: English
Weight: 532 KB
Volume: 11
Category: Article
ISSN: 1061-4036
DOI: 10.1038/ng1295-465

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sanfilippo syndrome in Turkey: Identific

Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B

✍ Serap Emre; Mugen Terzioglu; Aysegul Tokatli; Turgay Coskun; Imran Ozalp; Birgit 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

Sanfilippo syndrome (mucopolysaccharidosis type III, MPS III) is a progressive disorder in which patients are characterized by severe central nervous system degeneration together with mild somatic disease. MPS III results from a deficiency in one of the four enzymes involved in the degradation of he

The Mutation p.Ser298Pro in the sulphami

The Mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A Syndrome)

✍ Ann Meyer; Kai Kossow; Andreas Gal; Cordula Steglich; Chris Mühlhausen; Kurt Ull 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

## Communicated by Elizabeth F. Neufeld Mucopolysaccharidosis type IIIA (MPS IIIA, Sanfilippo A syndrome) is caused by mutations in the N-sulfoglucosamine sulfohydrolase (SGSH) gene and the resulting defective lysosomal degradation of the glycosaminoglycan heparan sulfate. The onset and progressio

Cloning of the rat agouti gene and ident

Cloning of the rat agouti gene and identification of the rat nonagouti mutation

✍ Takashi Kuramoto; Tomoko Nomoto; Takashi Sugimura; Toshikazu Ushijima 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 237 KB

Identification of 16 sulfamidase gene mu

Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A)

✍ Susanna Bunge; Hüseyin Ince; Cordula Steglich; Wim J. Kleijer; Michael Beck; Jac 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Communicated by Jürgen Horst Mucopolysaccharidosis type IIIA (MPS IIIA or Sanfilippo A disease) is a storage disorder caused by deficiency of the lysosomal enzyme sulfamidase. Mutation screening, using SSCP/heteroduplex analyses on cDNA and genomic DNA fragments, was performed in a group of 42

PRENATAL DIAGNOSIS OF SANFILIPPO A SYNDR

PRENATAL DIAGNOSIS OF SANFILIPPO A SYNDROME: EXPERIENCE IN 35 PREGNANCIES AT RISK AND THE USE OF A NEW FLUOROGENIC SUBSTRATE FOR THE HEPARIN SULPHAMIDASE ASSAY

✍ W. J. KLEIJER; E. A. KARPOVA; G. C. GEILEN; J. L. M. KEULEMANS; J. G. M. HUIJMAN 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

We have investigated the use of a 4-methylumbelliferone (MU)-derived artificial substrate, MU-a-D-Nsulphoglucosaminide, for the sulphamidase assay in chorionic villi and amniotic fluid cells. In the new two-step enzyme assay, fluorescent MU is released by the successive action of endogenous sulphami

Identification of molecular defects in I

Identification of molecular defects in Italian Sanfilippo A patients including 13 novel mutations

✍ Paola Di Natale; Nicola Balzano; Sabrina Esposito; Guglielmo R. D. Villani 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 1 views

Sanfilippo syndrome type A or mucopolysaccharidosis IIIA (MPS IIIA) is a lysosomal storage disorder caused by the deficiency of the enzyme heparin sulfamidase (EC 3.10.1.1), required for the degradation of the mucopolysaccharide heparan sulfate. Patients develop central nervous system degeneration r